Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular ...
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T ... Frontiers of Medicine has identified a pivotal ...
Yahoo Finance10 天
Over 15 CD39-Targeted Treatments in Clinical Trials, Market Opportunity Surges by 2025
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's ...
Yahoo Finance10 天
Over 15 CD39-Targeted Treatments in Clinical Trials, Market Opportunity Surges by 2025
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's ...